Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Molecular Templates Inc (MTEM)

Molecular Templates Inc (MTEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Will Molecular Templates Inc. (MTEM) Report Negative Q1 Earnings? What You Should Know

Molecular Templates Inc. (MTEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MTEM : 1.6400 (+5.81%)
TBPH : 9.17 (-0.54%)
Stocks Set to Open Lower as Investors Await FOMC Minutes, Inflation Data

June S&P 500 futures (ESM23) are down -0.21%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.34% this morning as market participants assessed recent labor market data while awaiting the release...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
JPM : 192.19 (-0.46%)
WFC : 60.23 (-0.61%)
C : 61.87 (-0.96%)
PXD : 275.75 (+0.08%)
FRC : 3.51 (-43.30%)
SQ : 72.11 (-2.59%)
MTEM : 1.6400 (+5.81%)
NTAP : 99.89 (-0.17%)
RBBN : 3.27 (+0.62%)
Molecular Templates Inc. (MTEM) Reports Q4 Loss, Lags Revenue Estimates

Molecular Templates Inc. (MTEM) delivered earnings and revenue surprises of -56% and 63.99%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

MTEM : 1.6400 (+5.81%)
HTGM : 0.4800 (-20.00%)
Adherex Technologies Inc. (FENC) Reports Q4 Loss, Lags Revenue Estimates

Adherex Technologies Inc. (FENC) delivered earnings and revenue surprises of -8.33% and 100%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

FENC : 9.07 (-1.84%)
MTEM : 1.6400 (+5.81%)
Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 32% and 13.53%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

HRTX : 2.68 (+1.13%)
MTEM : 1.6400 (+5.81%)
Spectrum Pharmaceuticals (SPPI) Reports Q4 Loss, Tops Revenue Estimates

Spectrum Pharma (SPPI) delivered earnings and revenue surprises of 33.33% and 5.35%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

SPPI : 1.0300 (unch)
MTEM : 1.6400 (+5.81%)
OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates

OptiNose (OPTN) delivered earnings and revenue surprises of -6.25% and 3.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

OPTN : 1.4400 (+55.63%)
MTEM : 1.6400 (+5.81%)
Molecular Templates Inc. (MTEM) Reports Q3 Loss, Tops Revenue Estimates

Molecular Templates Inc. (MTEM) delivered earnings and revenue surprises of 8.33% and 6%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

MTEM : 1.6400 (+5.81%)
PLXP : 0.0207 (unch)
Acutus Medical, Inc. (AFIB) Reports Q3 Loss, Tops Revenue Estimates

Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of 13.25% and 3.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

AFIB : 0.1632 (-2.16%)
MTEM : 1.6400 (+5.81%)
Stevanato Group (STVN) Q3 Earnings and Revenues Surpass Estimates

Stevanato (STVN) delivered earnings and revenue surprises of 7.69% and 0.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

STVN : 27.31 (+0.33%)
MTEM : 1.6400 (+5.81%)

Barchart Exclusives

Is This Pullback Your Best Chance to Buy Nvidia Stock?
As Nvidia experiences a pullback of approximately 18% from its recent highs, investors might be contemplating whether this presents an opportune moment to scoop up the stock. With concerns about valuation easing and analysts growing more bullish, this analysis explores whether now is the optimal time to consider investing in Nvidia. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar